Join Us at Cellicon Valley '23: The Future of Cell and Gene Therapies

Cellicon Valley '23:
The Future of Cell and Gene Therapies Educational Symposium


June 21-23, 2023

In Person at
Irvine Auditorium
3401 Spruce Street
Philadelphia, PA 19104
Virtually via AJI Media Livecast

Learning Objectives

Upon completion of this symposium, participants should be able to:

  • Identify current application of CAR T-cell therapy including: disease indication, accurate patient selection, manufacturing and treatment administration for adult and pediatric patients
  • Describe the latest for CAR T-Cell Therapy for T Cell ALL, multiple myeloma and CLL
  • List challenges and opportunities for equitable patient access
  • Explain the risk of malignancies and curative therapies for hemoglobinopathies
  • Identify the current status of globalization of cell and gene therapies
  • Describe the latest targets and technologies for CARs
  • Define toxicity and its management
  • Identify mechanisms of resistance and how to overcome it
  • List recent advances in cell therapy for solid tumors
  • Describe chimeric antigen receptor T Cells for T Cell malignancies
  • Identify the latest evidence based standards in nursing care resulting from the recent advances in cell therapy and transplant:
    • Identify advances in re-treatment
    • List the latest updates in fertility preservation
    • Describe the challenges with navigating and coordination of BMT/cell gene therapies and CAR-T
    • Explain how bispecific antibodies work
    • List standards of care and practice related to cell therapy infusion day
    • Repeat the rationale for nursing to remain current with new and upcoming therapies


April 4, 2023

Created by

Penn Physician VideoLink